58,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
29 °P sammeln
  • Broschiertes Buch

"Probabilistic predictions of future risk govern much of society: healthcare, genetics, social media, national security, and finance. Both policy-makers and private companies are increasingly working to design institutional structures that seek to manage risk by controlling the behavior of citizens and consumers, using new technologies of predictive control that comb through past data to predict and shape future action. These predictions not only control social institutions but also shape individual character and forms of practical reason. Risk-based decision theory shifts people's…mehr

Produktbeschreibung
"Probabilistic predictions of future risk govern much of society: healthcare, genetics, social media, national security, and finance. Both policy-makers and private companies are increasingly working to design institutional structures that seek to manage risk by controlling the behavior of citizens and consumers, using new technologies of predictive control that comb through past data to predict and shape future action. These predictions not only control social institutions but also shape individual character and forms of practical reason. Risk-based decision theory shifts people's relationships to the future through knowledge of possible dangers and foregone opportunities, thus inspiring anxious solicitude and deceptive hopes for total security. This book uses virtue ethics to analyze these problems and to suggest ways to enjoy these technologies' positive benefits while constraining their dangerous aspects through a better understanding of practical reasoning and a theological analysis of our responsibility for future risks"--
Autorenporträt
Paul Scherz is an associate professor of moral theology and ethics in the School of Theology and Religious Studies at the Catholic University of America. He is the author of Science and Christian Ethics. He has a PhD in theology from the University of Notre Dame and a PhD in genetics from Harvard University.